The aim of the study was to investigate whether an ''inapparent'' coinfection by hepatitis B virus (HBV) in anti-HCV-positive chronic liver disease patients may influence interferon (IFN) response. Fourteen anti-HCV-positive, hepatitis B surface antigen (HBsAg)-negative but serum HBV-DNA-positive pa
Back from the Future: Treating Hepatitis C Virus with Conventional Interferon
โ Scribed by Pankaj Puri; Vivek A Saraswat
- Book ID
- 117689904
- Publisher
- Elsevier
- Year
- 2012
- Tongue
- English
- Weight
- 126 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0973-6883
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We tested serial serum samples for hepatitis C virus RNA from patients undergoing treatment for chronic hepatitis C with interferon-a using an assay that combined reverse transcription and polymerase chain reaction. The subjects studied were 20 patients with chronic hepatitis who had serum antibody
The quantitation of hepatitis C virus (HCV) viremia RNA is measured by molecular techniques such as comcan be helpful in the diagnosis, therapy, and monitoring petitive reverse-transcription polymerase chain reacof patients with chronic hepatitis C. A sensitive and tion and branched DNA (bDNA) signa
Patients infected with hepatitis C virus (HCV) genotype 3 have a better response to interferon-โฃ (IFN-โฃ) therapy than those infected with genotype 1. There are extensive sequence differences between genotypes in the 3ะ half of the NS5a gene. An association between IFN-โฃ response and the interferon s
We quantified serum hepatitis C virus RNA titers and determined hepatltis C virus subtypes in chronic hepatitis C patients treated with interferon$ to investigate relationships among serum ALT response, serum hepatitis C virus titer and hepatitis C virus subtype. Of 146 chronic hepatitis C patients